Candidate genes for the hypoxic tumor phenotype

Cancer Research

Volumn 60, Issue 4, 2000, Pages 883-887

  Koong, Albert C ^a   Denko, Nicholas C ^a   Hudson, Karen M ^a   Schindler, Cornelia ^a   Swiersz, Lillian ^a   Koch, Cameron ^b   Evans, Sydney ^b   Ibrahim, Hani ^a   Le, Quynh T ^a   Terris, David J ^a   Giaccia, Amato J ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; ENDOTHELIN 2; FIBROBLAST GROWTH FACTOR 3; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MIGRATION INHIBITION FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN BCL 2; SOMATOMEDIN BINDING PROTEIN 3; VASCULOTROPIN;

ARTICLE; CANCER GENETICS; CELL HYPOXIA; CONTROLLED STUDY; GENE INDUCTION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HEAD CANCER; HUMAN; HUMAN CELL; NECK CANCER; PHENOTYPE; PRIORITY JOURNAL; REOXYGENATION; SQUAMOUS CELL CARCINOMA;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; LYMPHOKINES; MEMBRANE PROTEINS; MICE; NEOPLASMS; PHENOTYPE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034652779     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Thomlinson, R. H., and Gray, L. H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer, 9: 539-549, 1955.
2. Brown, J. M., and Giaccia, A. J. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res., 58: 1408-1416, 1998.
3. Green, S. L., and Giaccia, A. J. Tumor hypoxia and the cell-cycle: implications for malignant progression and response to therapy. Cancer J., 4: 218-223, 1998.
4. Brizel, D. M., Sibley, G. S., Prosnitz, L. R., Scher, R. L., and Dewhirst, M. W. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys., 38: 285-289, 1997.
5. Nordsmark, M., Overgaard, M., and Overgaard, J. Pretreatment of oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol., 41: 31-40, 1996.
6. Brizel, D. M., Scully, S. P., Harrelson, J. M., Layfield, L. J., Bean, J. M., Prosnitz, L. R., and Dewhirst, M. W. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res., 56: 941-943, 1996.
7. Hockel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., and Vaupel, P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res., 56: 4509-4515, 1996.
8. 2 homeostasis. Curr. Opin. Genet. Dev., 8: 588-594, 1998.
9. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelail growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
10. Graham, C. H., Fitzpatrick, T. E., and McCrae, K. R. Hypoxia stimulates urokinase receptor expression through a heme-dependent pathway. Blood, 91: 3300-3307, 1998.
11. Czyzyk-Krzeska, M. F., Furnari, B. A., Lawson, E. E., and Millhorn, D. E. Hypoxia increases rate of transcription and stability of tyrosine hydroxylase mRNA in pheochromocytoma (PC12) cells. J. Biol. Chem., 269: 760-764, 1994.
12. Bodi, I., Bishopric, N. H., Discher, D. J., Wu, X., and Webster, K. A. Cell-specificity and signaling pathway of endoihelin-1 gene regulation by hypoxia. Cardiovasc. Res., 30: 975-984, 1995.
13. Melillo, G., Musso, T., Sica, A., Taylor, L. S., Cox, G. W., and Varesio, L. A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med., 182: 1683-1693, 1995.
14. Jelkmann, W. Erythropoietin: structure, control of production, and function. Physiol. Rev., 72: 449-489, 1992.
15. Semenza, G. L, Roth, P. H., Fang, H-M., and Wang, G. L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem., 269: 23757-23767, 1994.
16. Wang, G. L., and Semenza, G. L. Purification and characterization of hypoxiainducible factor 1. J. Biol. Chem., 270: 1230-1237, 1995.
17. Huang, L. E., Arany, Z., Livingston, D. M., and Bunn, H. F. Activation of hypoxiainducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. J. Biol. Chem., 271: 32253-32259, 1996.
18. Kallio, P. J., Pongraiz, I., Gradin, K., McGuire, J., and Poellinger, L. Activation of hypoxia-inducible factor 1α: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc. Natl. Acad. Sci. USA, 94: 5667-5672, 1997.
19. 2 homeostasis by hypoxia-inducible factor 1α. Genes Dev., 12: 149-162, 1998.
20. Maltepe, E., Schmidt, J. V., Baunoch, D., Bradfiedl, C. A., and Simon, M. C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature (Lond.), 27: 403-407, 1997.
21. O'Rourke, J. F., Dachs, G. U., Gleadle, J. M., Maxwell, P. H., Pugh, C. W., Stratford, I. J., Wood, S. M., and Ratcliffe, P. J. Hypoxia response elements. Oncol. Res., 9: 327-332, 1997.
22. Koong, A.C., Chen, E. Y., and Giaccia, A. J. Hypoxia causes the activation of nuclear factor κB through the phosphorylation of IκBα on tyrosine residues. Cancer Res., 54: 1425-1430, 1994.
23. Karakurum, M. S. R., Chen, J., Pinsky, D., Yan, S. D., Anderson, M., Sunouchi, K., Major, J., Hamilton, T. K. K., Rot., A., Nowygrod, R., and Stem, D. M. Hypoxic induction of interleukin-8 gene expression in human endothelial cells. J. Clin. Investig., 93: 1564-1570, 1994.
24. Ausserer, W. A., Bourrat-Floeck, B., Green, C. J., Laderoute, K. R., and Sutherland, R. M. Regulation of c-jun expression during hypoxic and low glucose stress. Mol. Cell. Biol., 14: 5032-5042, 1994.
25. Yao KS, X. S., Curran, T., and O'Dwyer, P. J. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol., 14: 5997-6003, 1994.
26. Yan, S. F., Tritto, I., Pinsky, D., Liao, H., Huang, J., Fuller, G., Brett, J., May, L., and Stern, D. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J. Biol. Chem., 270: 11463-11471, 1995.
27. Yan, S. F., Zou, Y. S., Mendelsohn, M., Gao, Y., Naka, Y., Du Yan, S., Pinsky, D., and Stern, D. Nuclear factor interleukin 6 motifs mediate tissue-specific gene transcription in hypoxia. J. Biol. Chem., 272: 4287-4294, 1997.
28. Yan, S. F., Lu, J., Zou, Y. S., Soh-Won, J., Cohen, D. M., Buttrick, P. M., Cooper, D. R., Steinberg, S. F., Mackman, N., Pinsky, D. J., and Stern, D. M. Hypoxiaassociated induction of early growth response-1 gene expression. J. Biol. Chem., 274: 15030-15040, 1999.
29. Schmitt, M., Harbeck, N., Thomssen, C., Wilhelm, O., Magdolen, V., Reuning, U., Ulm, K., Hofler, H., Janicke, F., and Graeff, H. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb. Haemostasis, 78: 285-296, 1997.
30. Robert, C., Bolon, I., Gazzeri, S., Veyrenc, S., Brambilla, C., and Brambilla, E. Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor progression. Clin. Cancer Res., 5: 2094-2102, 1999.
31. Bajou, K., Noel, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D., and Foidart, J. M. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat. Med., 4: 923-928, 1998.
32. Chambers, S. K., Ivins, C. M., and Carcangiu, M. L. Plasminogen activator inhibitor-1 is an independent poor prognostic factor for survival in advanced stage epithelial ovarian cancer patients. Int. J. Cancer, 79: 449-454, 1998.
33. Kuhn, W., Schmalfeldt, B., Reuning, U., Pache, L., Berger, U., Ulm, K., Harbeck, N., Spathe, K., Dettmar, P., Hofler, H., Janicke, F., Schmitt, M., and Graeff, H. Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. Br. J. Cancer, 79: 1746-1751, 1999.
34. Lord, E. M., Harwell, L., and Koch, C. J. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res., 53: 5721-5726, 1993.
35. Evans, S. M., Joiner, B., Jenkins, W. T., Laughlin, K. M., Lord, E. M., and Koch, C. J. Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazoI-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide]. Br. J. Cancer, 72: 875-882, 1995.
36. Wang, G. L., and Semenza, G. L. Desferrioxamine induces erythropoielin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood, 82: 3610-3615, 1993.
37. Adam, M. F., Gabalski, E. C., Bloch, D. A., Oehlert, J. W., Brown, J. M., Elsaid, A. A., Pinto, H. A., and Terris, D. J. Tissue oxygen distribution in head and neck cancer patients. Head Neck, 21: 146-153, 1999.
38. Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. Hypoxia mediated selection of cells with diminished apoptotic potential in solid tumors. Nature (Lond.), 179: 88-91, 1996.
39. Young, S. D., and Hill, R. P. Effects of reoxygenation on cells from hypoxic regions of solid tumors: anticancer drug sensitivity and metastatic potential. J. Natl. Cancer Inst., 82: 371-380, 1990.
40. Rofstad, E. K., and Danielsen, T. Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis. Br. J. Cancer, 80: 1697-1707, 1999.
41. Amundson, S. A., Bittner, M., Chen, Y., Trent, J., Meltzer, P., and Fornace, A. J., Jr. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene, 18: 3666-3672, 1999.
42. Han, J., Sabbatini, P., and White, E. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E2B 19K. Mol. Cell. Biol., 16: 5857-5864, 1996.
43. Rajah, R., Valentinis, B., and Cohen, P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53-and IGF-independent mechanism. J. Biol. Chem., 272: 12181-12188, 1997.
44. Graham, C. H., Forsdike, J., Fitzgerald, C. J., and Macdonald-Goodfellow, S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int. J. Cancer, 80: 617-623, 1999.
45. Fitzpatrick, T. E., and Graham, C. H. Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen. Exp. Cell Res., 245: 155-162, 1998.
46. Pinsky, D. J., Liao, H., Lawson, C. A., Yan, S. F., Chen, J., Carmeliet, P., Loskutoff, D. J., and Stern, D. M. Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J. Clin. Investig., 102: 919-928, 1998.